ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.110

-1.4%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

CCS648

Fitzhughlaw

jargonweary

To: End2War who wrote (1048)	5/29/2025 2:39:09 PM
From: bobbseytwins2001	3 Recommendations Read Replies (5) of 1229

It appears that the already substantial IBRX short interest has risen about 6 million shares in the past two weeks. We have decades of experience in trading securities, and are at a loss to explain the strategy behind shorting a $2.50 stock in order to earn a profit. We are purely guessing that there is some kind of arbitrage happening here, but nothing in our experience explains how you make money doing it. If anyone can explain all this, please help us! We truly feel like the dumbest kids on the block. Investors buying and holding , while shorts supply them with shares? What are we missing?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next